1.Whentoday’shigh-schoolseniorsareaskedwhattheyplantodoaftergraduation,mostsaythattheyintendtogetbachelor’sdegree.Theyhavebeentoldthattheirgenerationhasonlyonewaytowinbygettingatleastabachelor’sdegree,inthehopethatitwilleventuallyleadtoaprofessionaljob.Inarecentsurveyofhigh-schoolseniorsconductedbytheNationalCenterforEducationStatistics,85percentoftherespondentssaidtheyplannedtogetbachelor’sdegree.And,although20yearsagoonly45percentofhigh-schoolgraduateswentontocollege,today68percentactuallymatriculate注册,withthemajorityenrollinginfour-yearortwo-yearprogramsdesignedtoallowthemtotransfertofour-yearinstitutions.Accordingtoconventionalwisdom,therapidriseinthenumberofstudentsattendingcollegeiscausefornationalcelebration.Butourresearchsuggeststhat,insteaditmaybecausefornationalconcern.Why?Becauseformanyyoungpeople,theonewaytowinparadigm例子isnotrealistic,giventheiracademictalentsandthelabor-marketprojections,Studentsrankingbelowthetopthirdoftheirhigh-schoolgraduatingclasstoooftenfailtoearnabachelor’sdegreeiftheyenrollincollege.Thecostofsuchfailure-inbothdollarsandunmetexpectationsisrisingandbeginningtoerodepublicconfidenceinoursystemofhighereducation.2.Asmallfamily-ownedcompany,Eisai,wasoneoftheoriginalmanufacturesofvitaminE,anditmaintainedastrongresearchcommitmenttonaturalpharmaceuticals.Overtheyears,itdevelopeddrugsforthetreatmentofcardiovascular,respiratory,andneurologicaldiseases.Thecompanyexperiencedsteady.Modestgrowth,andin1922salesreached197billionyenandprofitsapproached13billionyen.Althoughitwasthesixth-largestJapanesepharmaceuticalcompany.Eisaiwasarelativelysmallplayerinanindustryinwhichglobalcompetitionwasincreasingwhilegrowthinthedomesticmarketwasslowingdown.In1993,HaruoNaitotookoveraspresidentfromhisfather.Beforethat,hehadchairedEisai’sfive-yearstrategicplanningcommittee.Duringthattime,hehadbecomeconvincedthatthecompany’sfocusonthediscoveryandmanufactureofpharmaceuticalswasnotsustainableforlong-termgrowthagainstlarge,globalcompetitors.Twoyearsafterbecomingpr